Abstract Cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2) obtained from Solanum cernuum Vell. were assayed to explore their pharmacologic roles. Previous studies showed that (2) has selective activity against lung tumor cell line (NCIH460) which expresses high levels of COX-2, suggesting its role in inflammatory process, and also a link between chronic inflammation and cancerassociated process. Dichloromethane crude extract (DCE) significantly reduced writhing and stretching induced by 0.8 % acetic acid at a dose of 100, 300, and 600 mg/kg, po; oral administration of different doses of (1) and (2) also displayed significant analgesic and anti-inflammatory effects in the writhing acetic acid test (p \ 0.0001). Selected oral doses of both compounds (100 and 50 mg/kg) were assayed in the carrageenan-induced paw edema model. Compound (2) showed significant activity during the early phase (1.5-6 h) and also in the late phase (48 h) (p \ 0.01). The anti-nociceptive activity observed for the compounds (1) and (2) and DCE was found to be related to the inhibition of different mediators involved in inflammation and nociceptive process. Both compounds decrease COX-2 protein expression, although only compound (2) reached a significant response (p \ 0.05 vs control). However, in vitro Sirtuin 1 activity and TNF-a production in THP-1 macrophages were not affected.
Introduction
Perhaps because of income limitations, the use of medicinal plants by populations in developing countries remains common, large biodiversity and the resultant availability of medicinal plants, as well as a long tradition of use, contribute to the popularity of medicinal plant use. The World Health Organization (WHO) has estimated that *65 % of the world population uses plant-derived traditional medicines as their primary health care. Plant products also play an important role in the health care systems of developed countries (Cragg et al. 2009) .
One important example is the Solanum genus (Solanaceae family) that is used in a number of cultures. In addition to their nutritional value, Solanum species are valued for their medicinal properties (Jain et al. 2011; Vlachojannis et al. 2010) . Solanum cernuum Vell. is a Brazilian medicinal plant traditionally used in the treatment of gastric ulcers, hepatic injuries, skin disorders, and as anti-tumor, depurative, diuretic, antihemorrhagic and blennorrhoea agent (Corrêa 1984; Rodrigues and Carvalho 2001) . The leaves are also used as an infusion with tranquilizing action for cardiac disorders (Lorenzi and Matos 2000) .
Cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2) are cycloartane triterpenoids and the main constituents of the dichloromethane extract of S. cernuum Vell. leaves (Grando et al. 2008) . Compound 1 was found in Tinospora crispa that has been used in traditional medicine in Asia and Africa for its antipyretic and anti-inflammatory activities. Cardiotonic effects of compound 1 have been demonstrated (Kongkathip et al. 2002; Ramírez-Cisneros et al. 2012) , and more recently the cardioprotective effects of T. crispa have been described (Praman et al. 2011) . Despite the established anti-inflammatory properties of cycloartane triterpenoids (Rajic et al. 2001; Yang et al. 2010) no data have addressed similar effects with compounds 1 and 2.
Cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2) were tested against human tumor cell lines and 2 was significantly active and selective against lung tumor cell line NCI-H460. 1 showed less activity (Grando et al. 2008) . The high expression of cyclooxygenase 2 (COX-2) in the NCI-H460 cell line documented by Takahashi et al. (2002) supports the continued study of compounds 1 and 2 in inflammation and pain associated with inflammatory process.
In the present work we investigated the pharmacological properties of the dichloromethane extract of S. cernuum and of the isolated compounds cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2), in animal models of pain and inflammation. These studies have been complemented by in vitro studies.
Materials and methods
Plant material, extraction and isolation S. cernuum Vell. leaves were collected in Bragança Paulista (SP, Brazil) in September/2004 and Piracicaba (Esalq), in August/2009. The voucher specimens (VELL No 653) are deposited at the herbarium Frei Velloso of the São Francisco University (SP, Brazil). The oven-dried and powdered leaves were extracted with dichloromethane by maceration, providing the dichloromethane crude extract (6.7 % (w/w)). Cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2) were isolated, purified and identified as previously described. Both compounds were chromatographically pure which was confirmed by NMR spectroscopy and specific optical rotation values (Grando et al. 2008 ).
Drugs and reagents
The following drugs were used: carrageenan (SigmaAldrich, USA), piroxicam (Pfizer, NY, US), dexamethasone (Sigma-Aldrich, US), dimethyl sulfoxide (Synth, Brazil), tween-80 1 % (Sigma-Aldrich, US), acetic acid (Sigma-Aldrich, US), phorbol-12-myristate-13-acetate (PMA, Sigma-Aldrich, US), lipopolysaccharides from Escherichia coli O26:B6 (LPS, Sigma-Aldrich, US).
Experimental animals
Balb/C mice (20-35 g) obtained from CEMIB-Unicamp (Brazil) were maintained in a room with controlled temperature 25 ± 2°C for 12 h light/dark cycle, with free access to food and water. Animal care, research and animal sacrifice protocols were in accordance with the principles and guidelines adopted by the Brazilian College of Animal Experimentation (COBEA) and approved by the Biology Institute/UNICAMP-Ethical Committee for Animal Research.
Acute toxicity
Balb/C and Swiss mice were treated with compounds (1) and (2) at various doses (10, 30, 100, and 600 mg/kg) by po and ip routes. Groups were observed for the 4 h after administration and then daily for 14 days. The following variables were evaluated: general toxicity signals such as body weight loss, locomotion, behavior (agitation, lethargy), respiration, salivation, tearing eyes, cyanosis and mortality (Souza-Brito 1994) .
Acetic acid writhing assay
The DCE extract, compounds (1) and (2), and vehicle, were administered po at different dose (DCE 100, 300, and 600 mg/kg; (1) 50, 100, and 200 mg/kg; (2) 10, 50, and 100 mg/kg). Metamizole (200 mg/kg) was administered po Control (sham group) were administered saline 0.9 %. Animals were divided into 11 groups of 10 mice, consisting of DCE groups, compound (1), compound (2), each one with 3 dose of compounds, using metamizole as control/reference group (one dose), and control-sham group. Writhing was induced by an ip injection of 0.8 % acetic acid solution (10 mL/kg), 30 min after treatment. After acetic acid solution injection, the numbers of writhing (abdominal constrictions for nociception evaluation) were cumulatively counted over 15 min. Data represent the average of the total writhing observed, consortium number and percentage (Spindola et al. 2010 ).
Carrageenan-induced rat paw edema
Experiments were designed according to Posadas et al. (2004) and Nunes et al. (2007) with several modifications (Vendramini-Costa et al. 2010) . Right hind paw basal volume of Balb/C mice (n = 8/group) was measured using a plethysmometer (Panlab, Spain) and then were treated as follows: negative control (vehicle-saline 0.9 %), positive control (piroxicam-20 mg/kg, po), and experimental groups (1) (100 mg/kg) and (2) (50 mg/kg), both po route. After 1 h of treatment, inflammation was induced by inoculation of 40 ll of carrageenan 2.5 % into the right hind footpad and edema was determined by the difference between measured volume and basal volume and evaluated 1.5, 3.0, 4.5, 6.0, 24, 48, and 72 h after carrageenan inoculation. Results are expressed as variations in time of the paw edema (mL).
Cytokine TNF-a production and COX-2 expression in differentiated THP-1 cells Pro-inflammatory cytokine TNF-a production was quantified in supernatants from THP-1 differentiated macrophages from monocytic phase by PMA addition (200 nM, 24 h). An enzyme-linked immunosorbent assay (ELISA) was made according to the manufacturer's protocol (e-Biosciences, Biomol, PA, USA). Cells were previously stimulated with LPS (1 lg/mL). Dexamethasone (3.9 lg/mL) was used as anti-inflammatory control. Results were expressed as pg/mL of TNF-a produced in culture supernatants.
For the determination of COX-2 protein expression, first protein concentration of the homogenate was assayed following Bradford's colorimetric method. Aliquots of supernatants containing equal amounts of protein (50 lg) were separated on 10 % acrylamide gel by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In the next step, the proteins were electrophoretically transferred onto a nitrocellulose membrane and incubated with specific primary antibodies: COX-2 (M-19, Santa Cruz Biotechnology, CA) at a dilution of 1:1500. Each filter was washed three times for 15 min and incubated with the secondary horseradish peroxidase-linked anti-goat (for COX 2) antibody (Santa Cruz Biotechnology, CA). To prove equal loading, the blot was analyzed for b-actin expression using an anti-b-actin antibody (Sigma-Aldrich, Mo, USA). Immunodetection was performed using enhanced chemiluminescence light detecting kit (SuperSignal West Pico Chemiluminescent Substrate, Pierce, IL, USA). For the determination three independent studies were assayed.
Densitometric data were calculated following normalization to the control (house-keeping gene). The signals were analyzed and quantified (ImageJ, Image Analysis Software).
Sirtuin 1 activity assays
The effect of the compounds (1) and (2) in SIRT1 activity was monitored by quantifying the variations of the enzyme activity using the AK555 commercial kit (BIOMOL International, Plymouth Meeting, PA). The in vitro activity assay was performed by incubating recombinant human SIRT1 substrates with NAD? and peptide fluorogenic acetylated Lys382 p53 at 37°C, in accordance with technical instructions. Fluorescence was measured in a fluorimeter Synergy HT multi-mode microplate reader (BioTek Instruments) with an excitation wavelength of 360 nm and emission of 460 nm. Resveratrol has been used as internal control of activation, and nicotinamide and suramin sodium as inhibitory controls. SIRT1 activity was estimated after performing a calibration line constructed with increasing concentrations of fluorescent deacetylated peptide. Results are expressed in percentage of activity (%).
Statistical analysis
All values in the figures and text are expressed as mean ± standard error (SEM) of the mean of n observations. For the in vitro studies tables are representative of at least three experiments performed on different experimental conditions. On the acetic acid assay, results were analyzed by one-way ANOVA followed by Dunnett's t test for multiple comparisons; differences in the test-vs control-values were considered to be statistically significant at p B 0.05. In the carrageenan-induced paw edema differences in the test-vs control-values were considered to be statistically significant at p B 0.05. *p \ 0.05, **p \ 0.01, and ***p \ 0.001 following Duncan's Test. In in vitro studies (SIRT1 activity and TNF-a production) p-value \0.05 were considered significant and individual group means were then compared with Student's unpaired t test.
Results

Acute toxicity
No evidence of toxicity was observed 4 h after administration of (1) and (2) (10, 30, 100, and 600 mg/kg) by po and ip routes, as well as during the following 14 days, when the animals were kept under observation. Therefore, Pharmacological characterization of Solanum cernuum 181 the above dosages were considered safe for the following experiments (data not shown).
Animal studies of anti-nociceptive effect Table 1 shows results of acetic acid writhing reflex test. DCE from S. cernuum leaves, (1) and (2) significantly reduced writhings and stretching induced by 0.8 % acetic acid at a dose of 100 and 50 mg/kg, respectively. DCE significantly inhibited the writhing response and was dose dependent with 61.5 % (p \ 0.05) reduction observed for 300 mg/kg and 74.0 % (p \ 0.001) for 600 mg/kg. Both compounds show similar activity at dose of 50 mg/kg po (56.4 and 53 %) and are also dose dependent with 88.3 % (1) and 63 % with 100 mg/kg (2) respectively. Metamizole (200 mg/kg/po) had 90.5 % inhibition (Table 1) .
Carrageenan-induced edema
From the beginning (1.5 h) to the end of the experiment (72 h), compound (2), at dose of 50 mg/kg (po) significantly inhibited the paw edema induced by carrageenan. Piroxicam (20 mg/kg), employed as the positive control, had a similar profile although less effective than 24-oxo-31-norcycloartanone (2). Both compounds displayed significant anti-inflammatory activity during the early phase of the experiment. Piroxicam partly lost its anti-inflammatory properties at the end of the study (72 h), Fig. 1 . After 4.5 h of inflammation induction, (2) was notably more active than positive control, coinciding with the stage of COX-2 production and secretion of prostaglandins. Both (2) and positive control inhibited the second step of inflammation which occurs between 48 and 72 h after induction of carrageenan injection, but in contrast to the positive control, (2) presented inhibitory effect during all the late phase (after 6 h) (Fig. 1) .
COX-2 expression, TNF-a production, and SIRT 1 activity
We examined COX-2 expression by western blotting. Both compounds reduced the expression of COX-2 identified in culture supernatants of differentiated macrophages from the THP-1 monocytic line, and stimulated with LPS (1 lg/ mL), although a significant response was detected with compound 2 (24-oxo-31-norcycloartanone), p \ 0.05 vs LPS group (Fig. 2) . Resveratrol, as activation pattern, and nicotinamide and suramin were used as control of SIRT1 activation and inhibition respectively. Compounds (1) and (2) failed to produce a significant change on SIRT1 enzyme activity. Likewise, the production of the pro-inflammatory cytokine TNF-a in culture supernatants of THP-1 macrophages did not show any significant response after the addition of different compounds (data not shown).
Discussion
The present study showed that oral administration of dichloromethane crude extract (DCE) fraction of the leaves of S. cernuum Vell. (300 and 600 mg/kg) produces analgesic/anti-inflammatory effect as evidenced by the significant inhibition on writhing by acetic acid. The study was initiated with an acute toxicity test and revealed lack of toxicity for both compounds. Cycloeucalenone (1) at doses of 50, 100 and 200 mg/kg by oral administration, and 24-oxo-31-nor cycloartanone (2) at doses of 50 and 100 mg/kg po, show an important reduction of the number of contortions. In the paw edema assay, oral 24-oxo-31-nor cycloartanone (2) showed remarkable anti-inflammatory activity detected in early stages of inflammation (1.5-6 h) but also in later periods (48 h). The acetic acid writhing test model is a convenient stimulus assay for screening drugs with anti-inflammatory and/or analgesic activity because the intensity of response depends on the interaction of several factors (neurotransmitters/neuromodulators) that determine nociception (Shafiee et al. 2003) . Therefore, this model permitted the evaluation of antinociceptive activity produced by both neurogenic and/or inflammatory pain, and respond to analgesic substances possessing the most varied action mechanisms, being sensitive to drugs such as kinin receptor antagonists, opioid analgesics with central or peripheral action, or aspirin (Bjorkman et al. 1995; Spindola et al. 2010) . The writhing reduction produced by DCE, cycloeucalenone (1) and 24-oxo-3-norcycloartanone (2) maybe a consequence of an anti-inflammatory effect or an action on the conduct of pain signals through the sensory system.
To confirm the anti-inflammatory effects, cycloeucalenone (1) and 24-oxo-3-norcycloartanone (2) were evaluated by the carrageenan-induced paw edema model that has been accepted as a useful tool to study systemic anti-inflammatory agents. This model in mice has two distinct phases: the early phase starts immediately after carrageenan injection and lasts for about 6 h while the late phase starts after 6 h and ends at about 72 h after carrageenan injection, with an inflammatory peak being observed between 48 and 72 h (Nunes et al. 2007; Posadas et al. 2004) . Serotonin, phospholipase A 2 (PLA 2 ), histamine, kinins, arachidonate metabolites (prostaglandins, leukotrienes) and nitric oxide (NO) are mediators released in the early phase, while the later phases are suspected to be arachidonate metabolites producing an edema dependent on mobilization of neutrophils (Pedernera et al. 2010; Spindola et al. 2010) . The acute inflammatory response is characterized by an increase in vascular permeability and cellular infiltration leading to edema formation, as a result of extravasations of fluid and proteins, and accumulation of leukocytes at the inflammatory site (Posadas et al. 2004) . After inflammatory stimuli, mast cells are stimulated to produce histamine, which contributes to vasodilatation and vascular permeability. The inflammatory stimulus also leads to activation and secretion of mediators that include bradykinin and arachidonic acid metabolites such as prostaglandins and leukotrienes (Penissi et al. 2009) .
Compound 2 inhibited all inflammatory phases, effects that could result from a reduction of synthesis and/or secretion of mediators in the early inflammatory phase such as histamine and bradykinin, as well as a downstream inhibitory effect, interfering with the production of prostaglandins and leukotrienes, and subsequently an inhibition of leukocytes migration. Effectively, the assay of expression of COX-2 by western blotting demonstrates an inhibition of 24-oxo-31-nor cycloartanone (2) confirming that its analgesic and anti-inflammatory effect is COX-2-dependent. In comparison with positive control (the NSAID piroxicam) 24-oxo-3-norcycloartanone (2) was more active in both phases. Other possible explanations include a late indirect effect on cyclooxygenase activity by inhibiting leukocytes migration.
Considering the chemical structures of compounds 1 and 2 the difference is located at the side chain of the triterpenoids (Fig. 3) . The presence of an electron donor, the oxygen atom, in 2 could be the basis of the behavior of this compound in the carrageenan model assay. NAD-dependent protein deacetylase enzymes, Sirtuines (SIRT), are emerging as a novel molecular link between aging and various pathologies including those with an immune (1) and 24-oxo-31-norcycloartanone (2) on carrageenan-induced paw edema expressed as paw edema (mL) per time after inflammation induction. Mice were treated po with cycloeucalenone (100 mg/kg) (1), 24-oxo-31-norcycloartanone (2) (50 mg/kg), saline 0.9 % or piroxicam (20 mg/kg), 1 h before intraplantar carrageenan 2.5 % injection. Paw edema was evaluated in plethysmometer 1. component. The SIRT family comprises seven members (SIRT1 to SIRT7); in mammals SIRT1 affects cell survival and proliferation, lifespan, and inflammation through the deacetylation of proteins involved in these processes. Based on this knowledge, evidence suggests a role of SIRT1 in controlling the expression of several inflammatory mediators (Yoshizaki et al. 2009; Yoshizaki et al. 2010) . Several recent reports have established the sirtuindependent deacetylation of several transcription factors and specifically have demonstrated a role of SIRT1 in the deacetylation of the nuclear factor NF-jB. NF-jB can in turn regulate the expression of many genes involved in cytokines, including TNF-a, and many other regulators of an inflammation process (Ghosh and Hayden 2008; Yeung et al. 2004 ). There are many products of natural origin that can regulate the SIRT function, including those of terpenoids structure (Dao et al. 2010; Kang et al. 2010) . Although the cycloartane triterpenoids from S. cernuum, cycloeucalenone (1) and 24-oxo-31-norcycloartanone (2), have demonstrated their anticancer and anti-inflammatory properties, these responses are not related to direct activation of SIRT1. These results could also partly explain the lack of response in the cytokine TNF-a production. In the present study DCE and the isolated cycloartane triterpenoids showed analgesic activities as evidenced by its significant inhibition on writhing by acetic acid. Some doses of oral cycloeucalenone (1) and 24-oxo-3-norcycloartanone (2) were also evaluated in carrageenan-induced paw edema, a useful tool to study systemic anti-inflammatory agents. The results established an antiinflammatory activity of 24-oxo-31-nor cycloartanone (2) detected in early stages but also in later periods of inflammation. These results justify the ethnomedical claims. However, more investigations are required for a complete understanding of the mechanism of action.
